The analysis of tumors with SIX1 overexpression indicate that the oncogenic effect of SIX1 is associated with the repression of a senescent gene signature and the induction of a dedifferentiated tumor phenotype mediated, at least in part, by the stemness regulator Sox2. This evidence concerns the gene SOX2 and neoplasm.